Just Diagnosed

• What to Expect
• Treatment Options
• AML Clinical Trials
• Finding the Right Doctor
• Questions to Ask
• AML News

Invivoscribe Commitment

Invivoscribe is committed to finding targeted therapies that dramatically improve the prognosis for patients diagnosed with AML. The field of molecular diagnostics is rapidly changing the approach physicians and providers take when a patient is diagnosed with AML.

Visit Invivoscribe

 

Discussions

Join a discussion on our community boards.

View Community Boards

 

 

 

 

 

 

AML Clinical Trials

For the most recent up-to-date information on clinical trials for AML, please visit the Clinical Trials web site.

For Clinical Trials targeting FLT3, please visit LabPMM.com.